> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Prevacid IV Not Withdrawn For S&E
- URL: https://www.fdaweb.com/prevacid-iv-not-withdrawn-for-s-e/
- Published: 2016-09-08T12:00:00.000Z
- Updated: 2026-09-14T21:30:25.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136736

*Federal Register* Notice: FDA has determined that Prevacid IV (lansoprazole) intravenous injection, 30 mg/vial, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow the agency to approve ANDAs for lansoprazole intravenous injection, 30 mg/vial, if all other legal and regulatory requirements are met. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-09-08/pdf/2016-21551.pdf?ref=fdaweb.com)